Do we have to fear the “Public Option?”
The recent article "Tear Down This Firewall: Pharma Scientists Call for a Pre-competitive Approach to Bioinformatics" signals a watershed event in the evolution of commercial bioinformatics industry. Faced with the dual forces of budget pressures and need to invest or die, pharma is giving itself "permission" to consider economic alternatives to ...